What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients
Top Story
Archived
•
January 12, 2026
•
Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.
Source: https://feeds.feedburner.com/foxnews/latest - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



